Arranon (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Arranon drug offered from Novartis Pharmaceuticals Corporation. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | nelarabine |
| SUBSTANCE NAME: | NELARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-10-05 |
| END MARKETING DATE: | 0000-00-00 |
Arranon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Arranon from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2016-10-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0683_aa41d999-2473-40e9-842e-c8b98ecb27c2 |
| PRODUCT NDC: | 0078-0683 |
| APPLICATION NUMBER: | NDA021877 |
Other NELARABINE Pharmaceutical Manufacturers / Labelers:
